Wegovy vs Mounjaro: The Complete Treatment Comparison
Wegovy or Mounjaro Which Is Better: Understanding the Core Differences
When comparing Wegovy versus Mounjaro, the fundamental distinction lies in their active ingredients and hormonal mechanisms. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics a single natural fullness hormone, whilst Mounjaro utilises tirzepatide, a dual GIP and GLP-1 receptor agonist targeting two complementary pathways simultaneously. Both prescription-only medicines work by reducing appetite and promoting satiety, but their different approaches may suit different individuals depending on their metabolic profile and treatment response. The question of whether Wegovy or Mounjaro which is better ultimately depends on individual factors that your prescriber can assess during clinical evaluation.
Dosing schedules also differentiate these treatments, with Wegovy following a five-step escalation from 0.25mg to 2.4mg maintenance over 16 weeks, while Mounjaro progresses through six doses ranging from 2.5mg to 15mg maximum. Both require weekly injections using pre-filled pens, but the dose progression timelines and final maintenance levels vary significantly. Storage requirements favour Wegovy for travel convenience, maintaining stability for 6 weeks at room temperature compared to Mounjaro's 21-day limit once removed from refrigeration. These practical considerations can influence treatment choice for patients with active lifestyles or frequent travel commitments.
Wegovy vs Mounjaro Pricing: Treatment Costs and Value Comparison
EverydayMeds offers competitive pricing for both treatments, with Wegovy starter doses beginning at £79.99 and Mounjaro pricing structured differently due to its distinct dosing approach. Wegovy's dose progression costs are: £79.99 (0.25mg starter), £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), and £209.99 (2.4mg maintenance). New customers apply discount code FIRST40 at checkout, while returning customers use DOSE25 to reach these final prices. Bundle options provide treatment continuity, such as the Intro Duo (0.25mg & 0.5mg) for £169.99 or the Progress Trio (0.5mg, 1mg & 1.7mg) for £369.99.
When considering wegovy or mounjaro which is better from a cost perspective, both treatments represent significant investments in long-term weight management requiring ongoing commitment. Mounjaro's pricing structure reflects its different dosing regimen and dual-hormone formulation. The Ultimate Stability Trio provides three months of Wegovy maintenance supply (2.4mg ×3) for £649.99, offering treatment security without frequent reordering. Both treatments are available through our streamlined process with prescriber review and cold-chain delivery ensuring medication integrity from our GPhC-registered pharmacy (#9012878).
Clinical Evidence: How Wegovy and Mounjaro Compare in Weight Management Studies
Wegovy's efficacy is demonstrated through the comprehensive STEP trial programme, with STEP 1 showing participants achieved approximately 15% average weight loss at 68 weeks when combined with lifestyle interventions, compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The STEP 2 trial specifically examined patients with type 2 diabetes, reporting average weight reductions of 9.6%, while STEP 3 incorporated intensive behavioural therapy achieving 16% average weight loss. Long-term sustainability was examined in STEP 5, demonstrating 15.2% average weight reduction maintained at two years.
Mounjaro's clinical evidence comes from the SURMOUNT trial series, though direct comparison of percentage weight loss between trials isn't appropriate due to different study designs, participant populations, and endpoints. Both treatments showed cardiovascular benefits in their respective studies, with Wegovy's SELECT trial demonstrating 20% reduction in major cardiovascular events. When evaluating wegovy or mounjaro which is better, clinical evidence suggests both are effective prescription-only medicines requiring individual assessment to determine optimal treatment choice.
How Wegovy Works: The GLP-1 Weight Management Mechanism
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the action of glucagon-like peptide-1, a natural hormone released by the intestines after eating. This hormone targets specific receptors in the brain's appetite control centres, particularly the hypothalamus, reducing hunger signals and promoting feelings of fullness after smaller meals. The medication may also slow gastric emptying, helping food remain in the stomach longer and extending satiety between meals. Additionally, Wegovy can influence food reward pathways, potentially reducing cravings for high-calorie foods and making it easier to adhere to reduced-calorie eating plans. These combined mechanisms work alongside dietary changes and increased physical activity to support sustainable weight management outcomes.
Ordering Process: Getting Started with Wegovy or Mounjaro
EverydayMeds streamlines access to both treatments through our comprehensive online service, beginning with a 3-minute clinical assessment covering medical history, current medications, and weight management goals. Our qualified prescribers review applications within 3 working days as standard, with express 24-hour review available for urgent requirements. Once approved, medications are dispatched via next-day delivery using specialised cold-chain transport to maintain optimal storage temperatures throughout transit. All treatments originate from our GPhC-registered pharmacy (#9012878), ensuring authentic medicines meeting UK quality standards. The process eliminates traditional GP appointment delays while maintaining appropriate clinical oversight, with ongoing support available throughout treatment duration.
Storage and Practical Considerations: Wegovy vs Mounjaro Daily Use
Both treatments require refrigerated storage at 2-8°C before first use, but Wegovy offers superior travel flexibility with 6-week room temperature stability versus Mounjaro's 21-day limit once removed from refrigeration. Wegovy utilises Novo Nordisk's FlexTouch pen system, providing clear dose visualization and simple injection technique suitable for weekly self-administration. The pen design includes safety features preventing accidental needle sticks and clear dosing confirmation. Dose escalation follows a mandatory schedule over 16 weeks, allowing gradual tolerance development and minimising potential side effects. Both medications require injection into thigh, abdomen, or upper arm areas, with injection site rotation recommended to prevent tissue changes or reduced absorption effectiveness.
Wegovy or Mounjaro Which Is Better: Individual Factors That Determine Choice
The decision between these treatments depends heavily on individual medical history, previous weight loss attempts, concurrent medications, and lifestyle factors that your prescriber will evaluate. Patients with specific hormone sensitivities might respond differently to single-pathway GLP-1 stimulation versus dual GIP/GLP-1 activation. Some individuals may find Wegovy's storage advantages crucial for work travel or active lifestyles, while others might prefer Mounjaro's different dosing approach.
Treatment response varies significantly between individuals, with some patients achieving optimal results on lower doses while others require maximum maintenance levels for effectiveness. Your prescriber considers factors including diabetes status, cardiovascular risk profile, previous medication responses, and weight loss goals when determining which prescription-only medicine offers the best therapeutic match. Both treatments require long-term commitment, as clinical studies demonstrate weight regain when medication is discontinued without ongoing lifestyle maintenance.
Making Your Choice: Both Treatments Available at EverydayMeds
Rather than declaring wegovy or mounjaro which is better universally, EverydayMeds provides access to both options with expert clinical guidance to support individualised treatment selection. Our prescribers evaluate your complete medical profile, weight management history, lifestyle requirements, and treatment preferences to recommend the most appropriate option. Starting from £79.99 with discount codes FIRST40 for new customers or DOSE25 for returning patients, both treatments represent investment in professional weight management support. Visit https://everydaymeds.co.uk/collections/weight-loss to begin your clinical assessment today. Our GPhC-registered pharmacy ensures authentic medications with expert support throughout your weight management journey, recognising that the best treatment is the one that aligns with your individual needs and circumstances.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
